Excellent! So we may possibly see something like the following in the months ahead:
1-HDVY Signs Pancreatic Cancer Test Licensing Deal on a royalty based, worldwide co-exclusive basis to Quest Diagnostics Incorporated (NYSE: DGX) and Abbott (NYSE: ABT).
2- HDVY Signs New Breast Cancer Development Licensing Deal on a royalty based, worldwide co-exclusive basis to Quest Diagnostics Incorporated (NYSE: DGX) and Abbott (NYSE: ABT).